n CME : Your SA Journal of CPD - Protos : the first dual action bone agent for osteoporosis : health awareness
|Article Title||Protos : the first dual action bone agent for osteoporosis : health awareness|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||CME : Your SA Journal of CPD|
|Publication Date||Jun 2006|
Extracted from text ... health awareness June 2006 Vol.24 No.6 CMe 341 health awareness servier laboratories has announced the launch of its new osteoporosis drug Protos (strontium ranelate) in south africa. Indicated for the treatment of postmenopausal osteoporosis to reduce the risk of both vertebral and non-vertebral fractures, including the hip, Protos is a new first-line option in the treatment of postmenopausal osteoporosis. the first in a new therapeutic class, Protos is categorised as a 'dual action bone agent' as it has a particular profile which is characterised by a simultaneous inhibition of bone resorption and a stimulation of bone formation. now, for ..
Article metrics loading...